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The de novo formation of blood vessels (vasculogenesis) is an integral part of embryogenesis. Elucidation of the role
of cytokine cooperation in vasculogenesis may lead to a better understanding of organogenesis, blood vessel regulation
during tumorigenesis, and tissue injury. We have used embryonic stem cells to derive an endothelial cell line, designated
IEM, which expresses a range of endothelial markers, including Von Willibrand Factor VIII related antigen, vascular
cell adhesion molecule, platelet-endothelial cell adhesion molecule (CD31), and receptors for acetylated low-density
lipoprotein. More importantly, IEM cells can be induced upon exposure to combinations of basic ®broblast growth
factor and leukemia inhibitory factor (LIF) to proliferate and undergo vasculogenesis in vitro, resulting in the formation
of vascular tubes and microcapillary anastomoses. Moreover, exposure to both cytokines conditionally permits IEM
cells to speci®cally chimerize microvascular endothelium in vivo following blastocyst injection. These results indicate
that bFGF and LIF together contribute to the induction and support of embryonic vasculogenesis in an isolated endothe-
lial cell line. Our results provide evidence that combined actions of bFGF/LIF may play a role in mechanisms controlling
blood vessel development. q 1996 Academic Press, Inc.
INTRODUCTION ecule (PECAM-1), and ¯k-1, one of the tyrosine kinase re-
ceptors (RTK) for vascular endothelial growth factor (VEGF)
Blood vessels arise through the combined processes of (Cof®n et al., 1991; Baldwin et al., 1994; Yamaguchi et al.,
vasculogenesis (de novo formation of vessels by differentia- 1993). Interestingly, angioblasts, giving rise to the devel-
tion of angioblasts) and angiogenesis (elongation of preex- oping vasculature, are phenotypically similar to precursors
isting capillary heads). To date, vasculogenesis has been which form vasoformative neoplasms. Indeed, the migra-
demonstrated only in the developing embryo, while angio- tory and invasive nature of angioblast cells has been demon-
strated experimentally in chick±quail chimeras in whichgenesis mediates embryonic vessel formation, wound heal-
migrating angioblasts can be observed actively movinging, and tumor vascularization (Folkman, 1995). The endo-
throughout and around the graft site (Christ et al., 1991).thelial lineage arises from the primitive mesoderm during
In virally induced hemangiomas, endothelioma cells stimu-early pregastrulation development and depends upon endo-
late proliferation of host endothelial cells after invading anddermal induction (Palis et al., 1995). Primitive blood islands
penetrating existing vessels (Wilms et al., 1991; Williamscoalesce in the yolk sac to form a capillary network at the
et al., 1989). Regulatory pathways controlling normal em-same time that vasculogenesis occurs inside the embryo,
bryonic angioblasts from uncontrolled invasion, randomwhere primitive endothelial cells, or angioblasts, differenti-
migration, and continued growth after completion of theate in situ into vessel-forming structures (Parnadaud et al.,
homing process have yet to be described. Although the turn-1987). This intraembryonic vasculogenesis is characterized
over time of adult endothelial cells is extremely long, ma-by the expression of the endothelial markers Von Willibrand
ture endothelial cells are not permanently arrested and canfactor VIII (vWFVIII), platelet endothelial cell adhesion mol-
be switched back to a proliferative state upon stimulation
during wound healing or vascularization of tumors (Folk-
man and Shing, 1992). Endothelial cell lines retaining re-1 To whom correspondence should be addressed. Fax: (513) 559-
5827. E-mail: rlgendron@chmcc.org and robert.arceci@chmcc.org. sponsiveness to these switching mechanisms, particularly
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in response to speci®c cytokines, would be very useful in genic factors in the regulation of endothelial growth and
differentiation during the development of the mammalianfully understanding the molecular events underlying these
functional changes in endothelial differentiation. vasculature is not well understood. In other previously char-
acterized developmental systems, cytokine interactionsA number of angiogenic factors have been identi®ed, such
as acidic and basic ®broblast growth factor (bFGF), angio- have been observed to cause profound differentiative in¯u-
ences on early progenitor cell subsets, with differentiationgenin, transforming growth factors a and b (TGF-a and
TGF-b), tumor necrosis factor a (TNF-a), prostaglandins, proceeding either forward, to a more mature cell type (Palac-
ios et al., 1995), or backward, to a more primitive cell typeand VEGF, as well as physiological inhibitors of angiogene-
sis (reviewed in Folkman and Klagsbrun, 1987; Folkman (Pittack et al., 1991; Resnick et al., 1992; Matsui et al.,
1992). Embryonic stem (ES) cells will differentiate in a he-and Shing, 1992; Dickson et al., 1995; Pandey et al., 1995).
However, there is not yet a complete understanding of the matopoietic lineage-speci®c manner when cultured in com-
binations of interleukin-3 (IL-3), leukemia inhibitory factorcytokines and signals controlling the initial emergence of
angioblasts from mesoderm, induction of endothelium by (LIF), cytokine-family member interleukin-6 (IL-6), and liver
stromal cell supernatant in the presence of feeder cell layersendoderm, or the eventual organization and proliferation of
the more differentiated endothelium into the precursors of (Palacios et al., 1995). Primordial germ cells will proliferate
and transdifferentiate into primitive pluripotential embry-the vascular tree. Expression of VEGF, the ligand for the
two closely homologous RTKs ¯k-1 and ¯t-1, has recently onic stem cells in vitro when cultured in combinations of
stem cell factor (SCF), bFGF, and LIF (Resnick et al., 1992;been shown to be associated with areas of the embryo under-
going vasculogenesis and can lead to aberrant vasculogen- Matsui et al., 1992). In vivo, the LIF-cytokine family mem-
ber ciliary neurotrophic factor (CNTF) can interact withesis when overexpressed in mice (Millauer et al., 1993;
Drake and Little, 1995). Targeted inactivation of ¯k-1 re- bFGF to effectively maintain a primitive differentiative
stage of developing skeletal muscle ®bers (English andsults in a phenotype completely lacking both vascular and
blood island progenitor cells (Shalaby et al., 1995). Through Schwartz, 1995). Such cytokine interactions with LIF or
LIF family members in a variety of other early embryonicgene targeting, ¯t-1, in contrast to ¯k-1, has been demon-
strated to be involved in the structural assembly of the differentiation systems begs the question of whether LIF
might cooperatively interact with angiogenic cytokinesvasculature, but not for the initial differentiation of an-
gioblast cells (Fong et al., 1995). Targeted inactivation of such as bFGF in signaling mechanisms regulating embry-
onic endothelial cells. Although little is known about thethe TGF-b gene results in defects in both vasculogenesis
and hematopoiesis, suggesting that TGF-b may play an im- role of LIF family cytokines in vasculogenesis, recent obser-
vations indicate that this cytokine may indeed play a roleportant role in the development of the bipotential heman-
gioblast (Dickson et al., 1995). Other groups have demon- in early endothelial development and angiogenesis. Trans-
plantation experiments in chick have shown that LIF in¯u-strated the requirement of bFGF for the induction of vascu-
logenesis in embryoid bodies of quail (Krah et al., 1994). ences the ability of cardiac projenitors to rescue heart devel-
opment (Kirby et al., 1993). Targeted inactivation of theSince vasculogenesis occurs spontaneously in mouse em-
bryoid bodies, it is not yet known whether bFGF is abso- low-af®nity LIF receptor results in a reduction of the fetal
blood vessel component in the developing placenta, sug-lutely required for vasculogenesis in mammalian systems
(Risau et al., 1988; Wang et al., 1992). However, endoder- gesting that formation of the fetal vasculature may depend
partly on LIF (Ware et al., 1995). LIF appears to exert dif-mally derived bFGF stimulates vitilline vasculogenesis
through its receptors expressed in the developing yolk sac fering actions on endothelial growth depending upon the
tissue origin of the endothelial cells studied, stimulating(Yasuda et al., 1992). Furthermore, bFGF stimulates the ex-
pression of ¯k-1 mRNA at early stages in quail blastodisc growth in adrenal cortex capillary endothelial cells while
inhibiting growth of aortic endothelial cells (Ferrara et al.,cultures and this expression has been hypothesized to be
related to the differentiation of hemangioblasts from early 1992). Finally, LIF may be associated with endothelial
pathological processes as abnormally elevated levels of LIFepiblasts (Flamme et al., 1995). The RTKs tek, Tie-1, and
Tie-2 all have recently been shown to be involved in the have been detected in patients with giant cell arteritis, a
degenerative disease of the blood vessel wall (Lecron et al.,normal development of the embryonic endothelial lineage,
as expression patterns of these genes indicate speci®c local- 1993). No studies to date address the combined effects of
bFGF and LIF upon angiogenesis or vasculogenesis.ization in developing endothelium shortly after ¯k-1 expres-
sion is detected (Millauer et al., 1993; Yamaguchi et al., Model systems retaining responsiveness to angiogenic
and vasculogenic signals are needed to fully understand the1993; Sato et al., 1993). Null mutations of Tie-1 and Tie-2
RTKs reveal that expression of these genes is important for key regulators directing blood vessel development, progres-
sion, and assembly. These regulatory molecules could bevasculogenesis and angiogenesis. Furthermore, null mu-
tants for the RTK tek show defects in vascular and heart relevant to both developmental and tumor processes. We
hypothesized that isolated embryonic endothelium woulddevelopment (Dumont et al., 1994; Sato et al., 1995). How-
ever, studies of the signaling responses of these RTK mole- retain the ability to recapitulate vasculogenesis after im-
mortalization in vitro. Our central objective was to derivecules expressed later in endothelial development must
await the characterization of their respective ligands. a homogeneous model system in which speci®c cytokines
could be used to induce proliferative and differentiativeThe importance of interaction and cooperation of angio-
Copyright q 1996 by Academic Press, Inc. All rights of reproduction in any form reserved.
AID DB 8258 / 6x0f$$$461 06-08-96 02:15:59 dbal AP: Dev Bio
334 Gendron et al.
coverslip cultures of IEM cells or nonendothelial ®broblast controlchanges in isolated embryonic endothelial cells. Here we
cells with 10 mg/ml of diI-coupled a-LDL (Molecular Probes) for 4describe such a system in which the combined actions of
hr in medium containing 10% FBS under normal tissue culturebFGF and LIF induce vasculogenesis in an embryonic endo-
conditions. After incubation, the coverslips were retrieved, washedthelial cell line both in vitro and in vivo. Our results indi-
twice in PBS, mounted with glycerol±gelatin, and photographedcate that the combined action of these cytokines in¯uences
under a ¯uorescence microscope using a rhodamine ®lter.
the developmental pathway traversed by embryonic endo-
thelial cells and suggest that these cytokines may play a
role in directing the early formation of the vascular tree. Cytokine Reprogramming of IEM Cells to
Vasculogenic Colonies
The IEM cells were plated at 3.5 1 105 cells/ml in tissue cultureMATERIALS AND METHODS dishes in medium containing 10% FBS and allowed to adhere for
3±4 hr. This medium was then replaced with medium containing
Derivation of the IEM Cell Line 1% serum, LIF (1000±1500 units/ml), and bFGF (5±10 ng/ml). Cul-
tures were refreshed with bFGF and LIF on a daily basis. Control
ES cells, which are known to give rise to vasculogenic progenitors
cultures consisted of IEM cells plated and maintained in the same
in vitro (Risau et al., 1988), were grown in the presence of LIF on
manner but without cytokines. For the induction of vessel-like
gelatinized tissue culture plates in the absence of STO feeder cells.
structures in vitro, IEM colonies induced by bFGF/LIF exposure forThe ES cells were an early passage of the CCE line (Bradley et al.,
3 days were picked out and transferred to 35-mm plates containing1984). Con¯uent plates of ES cells were trypsinized and replated
a layer of 1 ml of Matrigel basement membrane matrix (Collabora-in complete Dulbecco's modi®ed Eagle's medium (DME) con-
tive Biomedicals) covered with DMEM containing 10% FBS. Un-taining 10% fetal bovine serum (FBS), LIF (1000 units per ml), and
treated IEM cells were transferred to separate Matrigel-coatedtestis conditioned medium (TCM) (1:100 dilution of a 0.45 mm-
plates for negative controls. Matrigel cultures were photographed®ltered solution made by homogenizing one adult mouse testis per
after 2 days.milliliter PBS). The TCM served as an enriched source of endoge-
Matrigel-embedded vasculogenic colonies were also ®xed in Bou-nous cytokines and solubilized exracellular matrix proteins and
in's ®xative, dehydrated, and embedded in glycomethacrylate plas-has a profound effect on ES cell differentiation (unpublished obser-
tic embedding compound. Hardened blocks were then thin sec-
vations). After 18 hr, the culture medium was replaced with sterile-
tioned at 2 mm thickness, stained with toluidine blue, and mounted
®ltered medium conditioned by c2 cells producing the pZIPTEX
in permanent mounting medium for viewing the internal architec-
retroviral vector containing the coding sequences for the early re-
ture of vasculogenic colonies.
gion of the SV40 Large T antigen and the dominant selectable neo-
mycin resistance gene (Brown et al., 1986). The viral titers of the
packaging cell supernatants ranged from 106 to 108 neopositive col- Growth Curves
ony-forming units per milliliter when tested on NIH 3T3 ®bro-
blasts. The c2 supernatant was supplemented with LIF and TCM Growth stimulation of IEM by bFGF (Gibco) and LIF (ESGRO;
at the concentrations speci®ed above. After infection, the cultures Gibco) was determined using the sulforhodamine B (SRB) assay, as
were incubated with selection medium containing geneticin (G418; previously described (Skehan et al., 1990). Brie¯y, cells were plated
Gibco) at 0.5 mg/ml, LIF, and TCM. Colonies surviving G418 selec- at 4000 or 7500 cells per well in 96-well plates (Costar) in medium
tion were picked with glass cloning cylinders, expanded, and main- containing 10% serum and allowed to adhere for 4 hr. The medium
tained in medium supplemented with G418 at 0.25 mg/ml. The was then replaced with medium containing 1% serum in the pres-
cloned IEM line was cultured in the presence of LIF and TCM for ence or absence of varying concentrations ofbFGF and LIF. Twenty-
approximately 1 month, after which time the line was switched to four or 72 hr later, the monolayers resulting from platings of 4000
complete DME containing 10% FBS and 0.25 mg/ml G418. For all and 7500 cells per well, respectively, were ®xed with 16.7% trichlo-
experimental procedures, IEM cells were cultured in the absence roacetic acid. The wells were then rinsed and stained with 0.4%
of G418 for 1 week prior to use. SRB in 1% acetic acid. After a further washing in 1% acetic acid
and drying, the SRB was solubilized with 10 mM Tris base, and
the absorbances were read at 530 nm in a Titertek multiwell plate
Endothelial Phenotyping of IEM Cells in Vitro reader.
Immunocytochemistry for endothelial speci®c markers was per-
formed on acetone-®xed coverslip cultures of IEM. Staining for Blastocyst Injection of IEM Cells and Analysis of
vWFVIII (Wagner et al., 1982) was performed using a rabbit poly- Chimeras
clonal anti-vWFVIII-related antigen (Dako) with a peroxidase-con-
jugated goat anti-rabbit second step (Promega). Staining for vascular Approximately 25±30 IEM cells from pools of individual colonies
generated by culture in 5±10 ng/ml bFGF and 1500 U/ml LIF werecell adhesion molecule (VCAM-1) and PECAM-1 (CD31) (Osborn
et al., 1989; Baldwin et al., 1994) was accomplished using rat mono- picked with a drawn-out Pasteur pipette and injected into C57/B6
host blastocysts at the 3.5 days postcoitum stage. Control injec-clonal anti-mouse-VCAM-1 and anti-mouse-PECAM-1 antibodies
(Pharmingen) and an alkaline phosphatase-conjugated goat anti-rat tions were done using the same number of untreated IEM cells
cultured in the absence of either cytokines or G418. The injectedsecond step (Promega). All reactions involving alkaline phosphatase
reagents were developed in the presence of levamisole to inhibit blastocysts were implanted into the uteri of pseudopregnant
B6CBAF/J foster mothers. After weaning, the pups (and in someendogenous tissue alkaline phosphatase reactions. All staining was
carried out at room temperature in 0.05 M Tris-buffered saline, pH cases the adult offspring) were screened for the presence of the
simin virus 40 (SV40) Large T genome by PCR and Southern blot7.5, in a humidi®ed chamber. Acetylated low-density lipoprotein
(a-LDL) uptake (Voyta et al., 1984) was determined by incubating analysis of genomic DNA. The initial screening for chimerization
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was accomplished by PCR ampli®cation of SV40 Large T sequences with a mean chromosome number of 54. The cell line ex-
in DNA isolated from the tails of offspring resulting from blastocyst presses endothelial markers such as vWFVIII, VCAM-1, and
injections. The SV40 Large T primers used were: 5* TCCAACCTA- PECAM-1 (CD31), and internalizes aLDL (Figs. 1a±1d, re-
TGGAACTGATG 3* (sense) and 5* AGTCAAGGCACTATA- spectively). The heterogeneity in staining patterns for
CATCA 3* (antisense). Reactions were carried out in a volume of VCAM-1 and PECAM-1 in the IEM cells (Figs. 1b and 1c)
40 ml for 40 cycles. The amplicon resulting from the PCRs of IEM
was also observed in human umbilical vein endothelial celland mouse tissue DNA was veri®ed to be speci®c by probing South-
(HUVEC) positive control preparations (not shown) and hasern blots of the PCR products using radiolabeled SV40 Large T
been reported previously by other groups as a characteristicsequences spanning the putative amplicon as a hybridization probe.
of marker expression by cultured endothelial cells (MasekFor Southern blots of genomic DNA, 20 mg of DNA was digested
with BclI, electrophoresed on a 1% agarose gel, and transferred to and Sweetenham, 1994). These marker expression charac-
nylon membranes under denaturing conditions. The blots were teristics clearly de®ne the cell line as having an endothelial
then cross-linked with UV light (Stratalinker) and probed with a phenotype (Wagner et al., 1982; Osborn et al., 1989; Bevilac-
32P-labeled (Feinberg and Vogelstein, 1983) 1500-bp fragment of the qua et al., 1987; Kwee et al., 1995; Cof®n et al., 1991; Bald-
SV40 early region situated 3* of the single BclI restriction site pres- win et al., 1994; Voyta et al., 1984; Alles and Bosslet, 1988;
ent in the retroviral vector (Brown et al., 1986). Vecchi et al., 1994). The endothelial mouse cell line was
Immunocytochemistry was performed on acetone-®xed frozen
designated IEM (Immortalized-(embryonal)-endothelium-sections of IEM chimeric tissues to localize IEM cells using the
mouse).SV40 Large T antigen as marker. The Large T epitope was stained
using a biotinylated anti-Large T mouse monoclonal antibody (Pha-
rmingen). Acetone-®xed frozen sections were preblocked with a bFGF and LIF Can Reprogram IEM Cells to Formbiotin±avidin blocking kit (Vector Laboratories). After incubation
Vasculogenic Colonies Containing Primitive Bloodwith anti-Large T, the staining reaction was developed with either
Vessels in Vitroan avidin±peroxidase or an avidin±alkaline phosphatase chromo-
gen substrate (Sigma). Chimeric tissues incubated with an irrele- Exposure of the IEM cells to a combination of bFGF and
vant biotinylated mouse anti-rabbit IgG were used as negative con- LIF results in a change in morphology characterized by a
trols. For double labeling studies, sections were ®rst stained for shift from monolayer to colony phenotype in 3 days (Fig.
Large T as described above and then stained with rabbit anti-
2b). The IEM cells do not form colonies in the presence ofvWFVIII using FITC-conjugated goat anti-rabbit second antibody.
LIF alone (Fig. 2c). Although the IEM cells display someDouble labeled slides were duplicate photographed under high dry
colony formation in the presence of bFGF alone (Fig. 2d), the400X or oil immersion under light and ¯uorescent (¯uorescein ®l-
maintenance and continued growth of the colonies dependster) conditions.
upon the simultaneous presence of LIF. Such colonies never
form in the absence of cytokines (Fig. 2a) and removal of
Animals bFGF and LIF results in the reversion of the IEM colonies
to a ¯at morphology over 2±3 days.
All experiments involving animals were performed in accordance The IEM cells show increased growth in response to bFGF
with the National Institutes of Health Guidelines on the Care and
alone, LIF alone, and combinations of both cytokines (Figs.Use of Laboratory Animals at Children's Hospital Research Founda-
3a±3c, respectively). The growth response of IEM cells wastion in Cincinnati, Children's Hospital Boston and Dana Farber
linear over at least a 3-day period. The maximal growthCancer Institute. Animal experiments were approved by the Ani-
response of IEM was achieved using a concentration of 5±10mal Care Committees at these institutions.
ng/ml of bFGF, while optimal concentrations of LIF ranged
between 250 and 2000 U/ml. In both cases, higher concen-
trations of either cytokine decreased the level of growthRESULTS
stimulation (Figs. 3a and 3b). Combinations of both cyto-
kines produced a partially additive growth response on IEMDerivation of an Embryonic Endothelial Cell Line
cells (Fig. 3c). IEM growth responses were optimal whenfrom ES Cells
bFGF concentrations between 5 and 10 ng/ml and LIF con-
centrations between 250 and 2000 U/ml were used (Fig.Embryonic stem cells can differentiate into primitive
mesenchyme containing vasculogenic progenitors in vitro 3c). Thus, the optimal concentration of each cytokine for a
growth response on IEM cells is not affected by the presence(Risau et al., 1988). Therefore, to isolate representatives of
early vasculogenic cells, a retroviral vector containing the of the other. These results demonstrate that in addition to
a differentiative signal to shift phenotype, a proliferativeSV40 Large T antigen was used to selectively immortalize
differentiated ES cell derivatives. One of the resulting signal is simultaneously induced by bFGF/LIF exposure in
IEM cells.clones showed a mesenchymal phenotype as demonstrated
by the expression of vimentin mRNA but not cytokeratin Matrigel was used in order to provide a collagen-con-
taining matrix for further support of differentiation of cyto-mRNA (not shown). This clone was expanded and estab-
lished as a permanent cell line. Southern and Western blot kine-induced IEM colonies (Zimrin et al., 1995). When
plated onto Matrigel basement membrane matrix, the IEManalyses veri®ed that the cells had integrated the SV40 ge-
nome and expressed Large T antigen (see below). colonies resulting from cytokine exposure sprout complex
blood vessel structures within 2±3 days, characteristic ofThe karyotype of the cell line was determined to be XY,
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FIG. 1. Endothelial-speci®c markers expressed in the IEM cell line in vitro. (a) Immunoperoxidase staining with a rabbit anti-vWFVIII-
related antigen. (b) Immunoalkaline phosphatase staining with rat anti-vCAM-1. (c) Immunoalkaline phosphatase staining with rat anti-
PECAM-1 (CD31). (d) Fluorescence staining of IEM cells after speci®c uptake of DiI-labeled acetylated-LDL; control ®broblast cells were
negative (not shown). (e) Absence of staining with nonimmune rabbit serum (NRS). (f) Absence of staining with rat IgG isotype control.
vasculogenesis (Figs. 4a±4c). Consistent with developing thelial cell (Figs. 4d and 4e). In addition, capillary anastomo-
ses are found in these colonies (Fig. 4f). Most likely dueembryonic blood vessels, thin sectioning reveals that the
IEM-derived blood vessel structures contain lumens and are to the low concentrations of endogenous bFGF present in
Matrigel (Collaborative Biomedical product speci®cations),predominantly composed of walls as thick as a single endo-
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Large T speci®c cDNA probe (Fig. 5, panel 1, a). PCR
followed by Southern analysis of tail DNA from all off-
spring injected with untreated IEM cells showed no SV40
Large T sequences (not shown). Moreover, PCR/Southern
blot analysis of organs in which the level of chimerism
obtained with cytokine-exposed IEM cells was more
abundant (spleen and thymus) failed to reveal chimerism
in animals resulting from blastocyst injection of un-
treated IEM cells. No SV40 sequences were detected in
these tissues, indicating that cytokine exposure was nec-
essary for the ability of IEM cells to chimerize vascular
tissues (not shown). The BclI restriction site, which is
present in the pZIP-TEX SV40 sequences but absent in
the LTR, was utilized to verify concordant proviral inte-
gration sites in the IEM cells and chimeric mouse ge-
FIG. 2. bFGF/LIF exposure induces phenotypic conversion of IEM
nomes. Southern blots of BclI-digested DNA probed withmonolayers to vasculogenic colonies. (a) Control IEM cells (no cyto-
a Large T fragment representing sequences upstream ofkines) on Day 3 of culture; phase-contrast. (b) Day 3 culture of IEM
the restriction site showed a similar banding pattern incells in the presence of bFGF and LIF showing enlarging colonies;
both tissues of the tail-positive mice and in the IEM cells,phase-contrast, 20X. (c) Day 3 culture of IEM cells in the presence
demonstrating that the tissues were chimeric rather thanof LIF alone; phase-contrast, 20X. (d) Day 3 culture of IEM cells in
the presence of bFGF alone; phase-contrast, 20X. positive due to infection during development (Fig. 5,
panel 1, b). Similar banding patterns between IEM cells
and chimeric tissue was also observed using pstI enzyme
digests [which also cuts once in the Large T gene and not
sprouting structures could sometimes be observed after un- in other viral sequences (not shown)]. The slight differ-
treated IEM cells were transferred to Matrigel. However, ences observed in the Southern blot banding intensity
tube formation in untreated cultures is delayed for up to 2 between IEM and tissue DNA are most likely due to the
days and is signi®cantly less extensive when compared to extreme differences in sample homogeneity, with IEM
cultures exposed to cytokines. Both a separate ES-derived being pure where experimental tissue is a mix of IEM and
SV40 Large T antigen immortalized cell line and STO em- nonchimeric tissues. A separate ES-derived SV40 Large T
bryo ®broblasts fail to undergo any observable phenotypic antigen immortalized cell line (designated ESD-2) which
shift after culture in bFGF and LIF, nor do they form vessel- was isolated simultaneously with IEM using the pZIP-
like structures on Matrigel. Interestingly, primary cultures TEX vector, showed a BclI banding pattern on Southern
of HUVEC cells also did not show a shift to colony pheno- blotting that was completely different from that found
type upon exposure to the same concentrations of bFGF in the IEM cells and chimeric tissues, demonstrating that
and LIF (not shown). These ®ndings indicate that bFGF/LIF the banding pattern in IEM was unique to the IEM cell
exposure induces a speci®c phenotypic shift of the IEM cells line (Fig. 5, panel 1, c). Chimerism was detected by South-
leading to the onset of vasculogenic changes in vitro. This ern blot in spleen, thymus, muscle, and brain while levels
result suggests that embryonic vasculogenesis may be sup- in lung, liver, heart, and uterus were below the level of
ported by combined actions of bFGF and LIF in vivo. detection (for example, compare heart and thymus lanes
in Fig. 5, panel 1, b).
Immunocytochemistry on frozen sections of tissuesExposure to bFGF and LIF Permits IEM Cells to from chimeric animals indicated that the location ofChimerize Developing Blood Vessels in Vivo
Large-T-positive IEM-derived cells was consistent with
the vascular compartment. Figure 5 (panel 2, a±f) demon-To examine the possibility that bFGF/LIF program-
ming in¯uences the potential of IEM cells to contribute strates the localization of Large T positive cells in the
splenic red pulp sinusoids and in the microcapillaries ofto developing blood vessels in an in vivo setting, mouse
blastocysts were injected with either cytokine-exposed the brain. The Large-T-positive cells were found within
areas of vWFVIII staining in consecutive sections of the(bFGF and LIF) or untreated IEM cells. Only the cytokine-
exposed IEM cells were able to contribute to vascular same organs (red pulp surrounding trebeculae in spleen
and microvessel linings in brain) as shown in Fig. 5, panelchimeras in resulting mice (Fig. 5, panels 1 and 2; Table
1). As expected, no chimerism could be detected by coat 2, c and f (also see below). No Large T staining was ob-
served in tissues from control noninjected mice (notcolor. However, PCR ampli®cation revealed that tail
DNA from 29% of the animals derived from injections shown). In order to con®rm that IEM cells chimerized
endothelial components rather than macrophages orof cytokine-exposed IEM cells contained SV40 Large T
antigen sequences (Table 1). The amplicons observed other cell types, double-labeling studies were performed
using anti-Large T and anti-vWFVIII antibodies to simul-after PCR of tail DNA were con®rmed to be speci®c for
SV40 Large T antigen by Southern blot analysis using a taneously label IEM derived cells and endothelial cells,
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FIG. 3. Growth of IEM cells in response to bFGF and LIF after 24 (a,b) and 72 hr (c) culture in cytokines as assessed by SRB staining of
total protein (ordinate) versus the concentrations of either bFGF (ng/ml), LIF (U/ml), or combinations of bFGF and LIF (abscissa). Values
are expressed as increases over control (no added cytokine) from means of pentuplicates from four separate experiments; standard errors
(not shown) were below 0.01 for each point.
respectively. The Large T and vWFVIII epitopes were co- T antigen staining pattern appears somewhat heteroge-
neous, since sections of positive cells contain variablelocalized at clusters of cells most heavily concentrated in
red pulp areas (those regions containing the endothelial portions of cytoplasm and nucleus, depending on the
plane of section. No Large T immunostaining was ob-sinusoids) as shown at high± dry magni®cation (Fig. 5,
panel 3, a±c). A double-stained IEM-derived cell photo- served in those organs showing no genomic IEM chime-
rism such as lung and uterus (not shown). Animals show-graphed under oil immersion is shown in Fig. 5, panel 3,
d±f. These results con®rm endothelial chimerization by ing IEM contribution were housed under standard condi-
tions into adulthood. Neither tumors nor ill health wereIEM cells in spleen. Unfortunately, chimerism of the thy-
mus could not be analyzed immunocytochemically due observed in either the IEM chimeric pups at birth or in
the adult IEM chimeric mice at ages up to 5 months. Noto limiting quantities of this tissue. The Large T immu-
nostaining pattern was both nuclear and cytoplasmic. Al- signi®cant alteration in Large T protein could be detected
by Western blot in cytokine exposed versus control cul-though T antigen distribution in cells expressing SV40
is mainly nuclear, some T antigen can also be detected tures (not shown). In addition, since it was readily de-
tected in the IEM chimeras, Large T does not appear toimmunocytochemically in the cytoplasm and at the cell
surface, as described previously in SV40 Large T be suppressed by either cytokine exposure or host in¯u-
ence in a long-term manner. These results demonstratetransgenic mice (Cheah et al., 1995). For this reason, the
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FIG. 4. Examples of blood vessel-like structures projecting from cytokine-induced IEM colonies 3 days after transfer to Matrigel; phase-
contrast (a) 101; (b,c) 201. (d±f) Thin sections of the same vasculogenic IEM Matrigel colonies as displayed above, showing cross-
sectional (d) and longitudinal (e) histological views of sprouting vessels composed of walls consisting of single endothelial cell thickness.
Microcapillary-like anastomoses are also observed and are shown in (f).
that cytokine stimulation of IEM cells leads to the induc- 1994). In addition, we have recent evidence that IEM cells
express the ¯k-1 RTK protein and that ¯k-1 is regulatedtion of a speci®c differentiative pathway permitting IEM
cells to develop in vivo with endogenous endothelium. upon cytokine exposure of IEM (manuscript in preparation).
Flk-1 is expressed in preangioblast mesoderm cells and angi-
oblast progenitors and is required for normal vascular and
hematopoietic development (Shalaby et al., 1995). The IEMDISCUSSION
cells contribute to blastocyst chimeras in vivo only after
exposure to bFGF/LIF. However, vasculogenic colonies de-The IEM cell line, derived from differentiated ES cells,
rived from cytokine-stimulated IEM cells in vitro are com-expresses vWFVIII, VCAM-1, and PECAM-1 (CD31). The
plex in structure but homogenous in cellularity, with noIEM cells also internalize aLDL in situ. These characteris-
evidence of accompanying spontaneous hematopoiesis.tics together clearly de®ne the IEM cell line as having an
These results indicate that the IEM cell line probably repre-endothelial phenotype (Wagner et al., 1982; Osborn et al.,
sents an early endothelial subset, most likely immortalized1989; Baldwin et al., 1994; Voyta et al., 1984; Alles and
at a point between the time after differentiation from aBosslet, 1988). Each of these markers (vWFVIII, VCAM-1,
bipotential hemangioblast and the point of early maturationand PECAM-1) are expressed at embryonic stages of endo-
into vessel-competent endothelium.thelial development, with PECAM-1 being one of the earli-
The response of IEM cells to bFGF and LIF exposureest adhesion molecule markers for developing endothelial
cells in the embryo (Baldwin et al., 1994; Vecchi et al., involves proliferation, a shift in morphology to a tightly
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FIG. 5. Cytokine exposure permits IEM cells to chimerize microvascular endothelium after blastocyst injection. Panel 1: (a) Representative
PCR ampli®cation of SV40 Large T sequences in tails of offspring from blastocysts injected with cytokine-exposed IEM cells (top).
Corresponding Southern hybridization of PCR gel using an SV40 Large T speci®c cDNA probe (bottom). IEM, lane 1; negative offspring,
lanes 2, 3, 4, and 7; positive offspring, lanes 5 and 6. (b) Representative genomic Southern blot analysis of the thymic tissue from a male
IEM chimera. Genomic DNA was digested with BclI. The blotted DNA was then probed with a 1500-bp Large T fragment speci®c for
Large T sequences upstream of the single BclI restriction site in the vector. (c) Genomic Southern blot analysis of IEM, lane 1, chimeric
thymic tissue, lane 2, and a separate, simultaneously derived SV40 immortalized cell line ESD-2, lane 3; Southern blotting was carried
out as described for b. Panel 2: Immunocytochemistry demonstrating IEM-derived Large T positive cells in IEM chimeric tissues. (a)
Spleen from an IEM chimera showing Large T positive cells localized in the red pulp sinusoids surrounding trebeculae. (b) Adjacent section
incubated with isotype control antibody showing no staining. (c) vWFVIII staining of a section closely adjacent to those shown in (a and
b) demonstrating the location of endothelial cells in red pulp sinusoids surrounding trebecular areas. (d) Brain from an IEM chimera
showing Large T positive cells localized in microcapillary endothelium. (e) Adjacent section incubated with isotype control antibody
showing no staining. (f) vWFVIII staining of a section adjacent to those shown in (d and e) demonstrating the location of endothelial cells
in brain microvascular capillaries. Panel 3: Double label immunocytochemistry showing identical ®elds of a cluster of vWFVIII-SV40 large
T positive IEM-derived cells localized in a splenic red pulp region (a,b) and high-power view of an individual IEM-derived cell expressing
both endothelial vWFVIII and SV40 Large T antigen in the splenic red pulp of an IEM chimera (d,e). (a,d) Immunoperoxidase staining of
SV40 T (red stain). (b,e) Simultaneous ¯uorescence staining of the same ®eld with anti-vWFVIII (green granular staining). (c,f) Negative
control spleen sections incubated with normal rabbit serum in place of anti-vWFVIII followed by FITC-tagged anti-rabbit (background
staining). a,b, and c were photographed at 401, while d,e, and f were photographed under oil immersion at 100X.
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TABLE 1 without bFGF/LIF preexposure may not have suf®cient
Incidence of IEM Chimerism for Blastocyst Injections with either time of stimulation by endogenous cytokines in the blasto-
Cytokine-Exposed or Untreated IEM Cells cyst for these cells to shift phenotype in synchrony with
developmental events directing endogenous endothelial
Injected Number cell differentiation. That IEM cells show reduced and de-
Treatment embryos Individuals of pups Number
layed vasculogenic colony formation compared to cytokineof cells transferred pregnant born chimeric
exposed IEM in vitro also lends support to the requirement
bFGF / LIF 45 6/6 21 6 and speci®city for a timely bFGF/LIF stimulus. If the cyto-
None 51 5/6 15 0 kine-induced IEM response was not involved with a devel-
opmental mechanism associated with endothelial differen-
tiation, one of three possible experimental outcomes could
be predicted to occur after blastocyst injection. The ®rst
possibility is that IEM contribution would not have beenpacked colony phenotype, and the aquisition of the ability
to form complex vasculogenic structures in vitro after observed in vascular compartments of animals resulting
from blastocyst injection with cytokine-treated cells. Intransfer to matrix layers. Moreover, bFGF/LIF stimulation
permits IEM cells to codevelop with normal endothelial the second possible outcome, IEM contribution would
have been observed in random nonvascular compartmentsprogenitors in blastocyst chimeras in vivo. The cytokine
requirements in IEM cells suggest a role for bFGF/LIF syn- of animals resulting from blastocyst injection with either
untreated or cytokine-treated cells. The third possibility isergy in vasculogenic processes. Although such a response
has not been demonstrated previously for endothelial cells, that both untreated and cytokine-exposed IEM cells would
have proliferated uncontrolled as tumors in the developingtransdifferentiative changes in response to combinations
of bFGF and LIF have been described for cells in other blastocysts and disrupted embryo development, as is ob-
served with embryonal carcinoma cells (Rossant and Mc-systems. For example, primordial germ cells and devel-
oping skeletal muscle cells undergo profound growth and Burney, 1982). That none of these outcomes occurred and
that speci®c vascular chimerism was detected only afterphenotypic shifts in response to combinations of bFGF and
LIF or bFGF and CNTF (another closely related cytokine cytokine exposure indicates that the combined bFGF/LIF
stimulus must activate a novel vasculogenic responseof the LIF family), respectively (Resnick et al., 1992; Mat-
sui et al., 1992; English and Schwartz, 1995). The IEM pathway in the IEM cells. These results suggest a similar
mechanism may play a role in activating endogenous vas-response demonstrates that bFGF/LIF induces a speci®c
activation pathway directing IEM cells to form vascular culogenesis in the developing embryo.
Both bFGF and LIF, in addition to their respective receptorstructures and suggests that the bFGF/LIF combination
may have similar effects on intrinsic endothelial projeni- components, are expressed in the developing embryo or yolk
sac during the stages in which vasculogenesis occurs, mak-tors in vivo. Alternatively, bFGF/LIF may not be important
in vivo since untreated IEM cells do not chimerize blasto- ing plausible an argument for their combined role in vascu-
logenesis during development (Rathjen et al., 1990; Saito etcysts. However, it is likely that endogenous bFGF/LIF in
vivo may exert an effect upon endothelial cells or endothe- al., 1992; Yasuda et al., 1992). In the avian embryo, bFGF
is expressed at stages during which angioblasts arise andlial precursors at a stage much later than that represented
by 3.5-day blastocysts, which have not yet developed prim- appears to potently induce the expression of VEGF receptor
during vasculogenesis (Mitrani et al., 1990; Flamme et al.,itive mesoderm, the precursor to angioblasts. Moreover,
3.5-day blastocysts have not yet developed extraembryonic 1995). In mouse, it has been demonstrated that endoder-
mally derived bFGF acts upon the endothelial progenitorsendodermal tissues, which are thought to induce angio-
blasts to commence vasculogenesis and have also been expressing bFGF receptor (¯g) (Yasuda et al., 1992). As null
mutants have not been described for these genes it is dif®-shown to be a major endogenous source of both bFGF and
LIF in the developing embryo (Christ et al., 1991; Wilms cult to predict the absolute requirement for bFGF/¯g during
mouse vasculogenesis in vivo. However, in quail blastodiscet al., 1991; Yasuda et al., 1992; Rathjen et al., 1990). Sur-
vival of IEM cells in the blastocoele cavity after injection isolate cultures, it is clear that vasculogenesis absolutely
depends upon the presence of bFGF (Krah et al., 1994). Vas-may be dependent upon mechanical requirements related
to adhesion or migration. The injected IEM cells may re- culogenesis occurs spontaneously in mouse embryoid bod-
ies, but the presence and level of endogenous bFGF may bequire exposure to exogenous bFGF/LIF to ful®ll such re-
quirements until endogenous cytokines produced to act quite different in each species as may be a requirement
for a timed burst of this cytokine to stimulate endothelialupon developing endothelium are present. Since chime-
rism is not found in animals resulting from blastocyst in- precursors (Risau et al., 1988; Wang et al., 1992). Although
the phenotype of the LIF null mouse does not show anyjections of untreated IEM cells, these IEM cells must have
died and/or become diluted out at some point after injec- vascular abnormalities (Stewart et al., 1992), other redun-
dant cytokines such as CNTF or IL-6, which signal throughtion, supporting the argument that exogenous bFGF/LIF is
required for their support. In addition, the full cytokine- the same receptor component (gp130; Ip et al., 1992), may
compensate for any effects that absent LIF family membersinduced shift to colony phenotype occurs over a period of
3 days in culture. IEM cells introduced into blastocysts may exert on developing endothelium. Mice harboring a
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null mutation for the low-af®nity LIF receptor (LIFRb) show of differentiation. These observations also emphasize the
importance of deriving separate model systems mimickingabnormalities in placental vasculature, suggesting that LIF
effects signaled through this particular receptor subset may the heterogeniety of endothelial cell subsets during both
development and adulthood.indeed be important for the development of subgroups of
endothelial cells (Ware et al., 1995). Other cytokines and There is little understanding of the mechanisms by which
combinations of cytokines and growth factors in¯uence cel-RTK receptors including VEGF, ¯k-1, ¯t-1, tek, Tie-1, and
Tie-2 have been demonstrated by either expression studies lular processes. Signaling pathways of individual cytokines
and growth factors are not fully understood. Therefore, itand/or gene targeting to be important for various aspects of
the development of the vascular tree (Millauer et al., 1993; is of central importance to elucidate the mechanism by
which bFGF and LIF induce the reprogramming of IEM cellsFong et al., 1995; Yamaguchi et al., 1993; Sato et al., 1993;
Dumont et al., 1994; Sato et al., 1993). Whether or not into a vasculogenic phenotype. Our preliminary results
show that the immediate-early responses of IEM to bFGFthese other cytokines might interact with bFGF/LIF in vivo
remains to be investigated. However, we have recently ob- and LIF stimulation are similar to those observed in other
systems (unpublished results). The molecular events de-served that the IEM cells also express the VEGF RTK ¯k-1
protein, suggesting that IEM cells might also be capable of termining the developmental IEM response to these cyto-
kines (phenotypic shift) probably results from subsequentresponding to VEGF (manuscript in preparation). Since the
vasculogenesis process in quail appears to involve interac- downstream events such as transcriptional changes rather
than a unique immediate-early response pattern. We aretions between bFGF and the VEGF receptor ¯k-1 (Flamme
et al., 1995), the IEM model will be a useful means for currently investigating the transcriptional responses to
bFGF and LIF in the IEM system.further investigating the details of signaling mechanisms
associated with cytokine interactions during vasculogenesis The effect of bFGF/LIF exposure in IEM cells involves
proliferation and differentiation simultaneously. The onlyin a homogenous mouse system.
The response of the IEM cells to bFGF and LIF involves other case in which a similar response pattern has been
described for these cytokines in vitro is in primordial germboth proliferation and a transdifferentiative shift to a differ-
ent phenotype. Growth response of IEM cells indicates that cells, where bFGF and LIF, in the presence of stem cell
factor (SCF), induces transdifferentiation and proliferationa speci®c range of concentrations of bFGF and LIF, either
alone or in combination, are optimal in inducing growth simultaneously, leading to the proliferation of primordial
germ cells as embryonic stem cells (Resnick et al., 1992;(5±10 ng/ml and 250±2000 U/ml, respectively) of the IEM
cells. The speci®c range of concentrations of bFGF and LIF Matsui et al., 1992). Interestingly, HUVEC cells, which
should approximate normal mature endothelium, failed toinducing maximal growth are the same when used alone or
in combination. The combinatory growth effect of bFGF show a similar phenotypic shift in response to bFGF/LIF
exposure, suggesting that this response is speci®c for earlyand LIF is partially additive, suggesting a saturation of the
growth stimulation response. At higher concentrations of embryonic stages of endothelial differentiation. Our results
provide the ®rst evidence that vasculogenesis may also in-bFGF and LIF (10±15 ng/ml and 2000±10,000 U/ml range,
respectively), suboptimal growth stimulation is achieved. volve simultaneous proliferative and differentiative changes
leading to a profound shift in phenoype.Similar growth responses have been observed in other sys-
tems. Decreased effects at higher cytokine concentrations The IEM cells display cytokine responsiveness, undergo
vasculogenesis in vitro and can chimerize developing andhave been previously described for primordial germ cells
(Resnick et al., 1992; Matsui et al., 1992). LIF has recently adult vascular structures despite the expression of SV40
Large T antigen. We have been unable to detect any signi®-been shown to inhibit angiogenesis, although the concentra-
tions of LIF required to achieve such inhibition are an order cant changes in the level of expression of SV40 protein dur-
ing the in vitro responses of IEM cells to cytokine stimula-of magnitude higher than concentrations normally effective
for stimulating growth in the IEM cells (Pepper et al., 1995) tion, indicating that such phenotypic changes are not ac-
companied by changes in expression of Large T in the IEMor for stimulating signal transduction in a number of other
well-de®ned LIF-responsive cell types including myeloid cells. Therefore, the bFGF/LIF-mediated proliferation, col-
ony formation, and vasculogenesis are most likely not asso-leukemia cells, neurons, and primordial germ cells (Lord et
al., 1991; Ip et al., 1992; Resnick et al., 1992; Matsui et ciated with changes in the expression level of SV40 Large T.
We have been unable to suppress Large T protein expressional., 1992). LIF concentrations reported to be inhibitory to
angiogenesis fall within the refractory region of the IEM using speci®c antisense oligonucleotides for the purpose of
addressing whether the differentiative or growth responsesresponse (10,000 U/ml), suggesting that endothelial re-
sponses to LIF may be highly concentration dependent. are directly affected by SV40 expression (unpublished obser-
vations). However, since SV40 Large T antigen can be ex-Moreover, LIF appears to have highly variable effects upon
different endothelial cell subsets, with major differences ob- pressed in normally differentiating and proliferating tissues
from embryonic stages through adulthood without any ap-served in growth inhibition of aortic versus microvessel
endothelium (Ferrara et al., 1992). Our observations coupled preciable adverse effects (Shida et al., 1992), it is likely that
the expression of SV40 Large T antigen by the IEM cellswith others in the literature suggest that endothelial re-
sponses to LIF vary considerably with the heterogeneity of does not affect the proliferative and differentiative changes
observed upon cytokine exposure.endothelial cells from different organs and different stages
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